Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitable Holdings
EQH
|
+$23M |
| 2 |
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
|
+$22.4M |
| 3 |
Sherwin-Williams
SHW
|
+$15.8M |
| 4 |
Merck
MRK
|
+$15.1M |
| 5 |
Norfolk Southern
NSC
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$23.7M |
| 2 |
DuPont de Nemours
DD
|
+$15.1M |
| 3 |
Wynn Resorts
WYNN
|
+$12.7M |
| 4 |
NVIDIA
NVDA
|
+$9.64M |
| 5 |
Cigna
CI
|
+$9.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.45% |
| 2 | Consumer Discretionary | 16.21% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 12.58% |
| 5 | Technology | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Lamb Weston
LW
$7.38B
| $2.23M | 0.12% |
+32,600
| New | +$2.13M |
|
252
BrightView Holdings
BV
$1.05B
| $2.19M | 0.12% |
+100,000
| New | +$2.17M |
|
|
INN
253
Summit Hotel Properties
INN
$664M
| $2.19M | 0.12% |
153,100
+134,724
| +733% | +$1.95M |
|
|
WCN
254
Waste Connections
WCN
$42.6B
| $2.19M | 0.12% |
29,099
+8,682
| +43% | +$649K |
|
|
ARR
255
Armour Residential REIT
ARR
$2.31B
| $2.17M | 0.12% |
19,040
+13,140
| +223% | +$1.51M |
|
256
Jefferies Financial Group
JEF
$12.1B
| $2.17M | 0.12% |
+106,431
| New | +$2.23M |
|
|
PLYA
257
DELISTED
Playa Hotels & Resorts
PLYA
| $2.16M | 0.12% |
199,965
+18,179
| +10% | +$194K |
|
258
Affiliated Managers Group
AMG
$9.21B
| $2.13M | 0.12% |
+14,292
| New | +$2.36M |
|
259
Perrigo
PRGO
$1.98B
| $2.13M | 0.12% |
29,138
+14,153
| +94% | +$1.09M |
|
|
DCH
260
Dauch Corp
DCH
$1.63B
| $2.12M | 0.12% |
136,300
+117,031
| +607% | +$1.88M |
|
|
RAD
261
DELISTED
Rite Aid Corporation
RAD
| $2.12M | 0.11% |
+61,250
| New | +$2.08M |
|
|
K
262
DELISTED
Kellanova
K
| $2.1M | 0.11% |
+31,950
| New | +$1.9M |
|
|
BLUE
263
DELISTED
bluebird bio
BLUE
| $2.04M | 0.11% |
+1,004
| New | +$2.29M |
|
|
SEM
264
DELISTED
Select Medical
SEM
| $2.03M | 0.11% |
+207,163
| New | +$2.03M |
|
265
United Therapeutics
UTHR
$22B
| $2.02M | 0.11% |
+17,900
| New | +$1.97M |
|
266
Interactive Brokers
IBKR
$42.5B
| $2.02M | 0.11% |
+125,604
| New | +$2.27M |
|
267
Ingredion
INGR
$6.74B
| $2.02M | 0.11% |
+18,279
| New | +$2.15M |
|
268
Axogen
AXGN
$2.71B
| $2.01M | 0.11% |
40,000
-80,000
| -67% | -$3.52M |
|
269
Honeywell
HON
$68.4B
| $2.01M | 0.11% |
+15,428
| New | +$2.05M |
|
270
Ameriprise Financial
AMP
$49.1B
| $2M | 0.11% |
14,315
+4,204
| +42% | +$596K |
|
271
UDR
UDR
$12.1B
| $1.98M | 0.11% |
52,696
+42,421
| +413% | +$1.53M |
|
|
ECYT
272
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.94M | 0.1% |
140,200
-245,315
| -64% | -$2.91M |
|
273
Trupanion
TRUP
$1.36B
| $1.93M | 0.1% |
50,000
-20,000
| -29% | -$621K |
|
|
GSKY
274
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.93M | 0.1% |
+91,083
| New | +$2.18M |
|
275
Jack in the Box
JACK
$331M
| $1.92M | 0.1% |
22,600
+18,248
| +419% | +$1.58M |
|
Similar funds
Steve Schonfeld's Q2 2018 Portfolio in Review
As of Q2 2018, Steve Schonfeld held 1,111 positions worth $1.84B, up 38% from $1.33B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Steve Schonfeld deployed $511M of net new capital in Q2 2018, opening 387 new positions and adding to 195 existing holdings. Its largest new stake was Equitable Holdings: 1,082,300 shares worth $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Wynn Resorts, an estimated $12.7M trimmed.
- Steve Schonfeld's largest Q2 2018 buy was Equitable Holdings: 1,082,300 shares worth $22.3M.
- Steve Schonfeld added most to Sherwin-Williams in Q2 2018, an estimated $15.8M increase.
- Steve Schonfeld's biggest Q2 2018 reduction was Wynn Resorts, cutting an estimated $12.7M.
- Steve Schonfeld fully exited Meta Platforms (Facebook) in Q2 2018, selling an estimated $23.7M.
- Steve Schonfeld's ten largest holdings make up 9.8% of its $1.84B portfolio in Q2 2018.
- Steve Schonfeld opened 387 new positions and closed 373 in Q2 2018.
- Steve Schonfeld's portfolio value rose 38% quarter-over-quarter to $1.84B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.